government website clinicaltrials.gov, was designed to test an oral version of BPC-157 for safety and for how it is processed by the body
Instead of overcoming the metabolic adaptation, higher doses frequently exacerbate side effects like nausea, fatigue, and gastrointestinal distress
High-purity BPC-157, GHK-Cu,TB-500 supplied together exclusively for laboratory and research applications
Mechanistically, AOD 9604 targets 3-adrenergic receptor signaling in adipose tissue models
AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment